Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;27(1):13-21.
doi: 10.15274/NRJ-2014-10002. Epub 2014 Feb 24.

Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT

Affiliations

Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT

Madhavi Tripathi et al. Neuroradiol J. 2014 Feb.

Abstract

Positron emission tomography (PET) imaging with F-18 fluorodeoxyglucose (FDG) can be used as a downstream marker of neuronal injury, a hallmark of neurodegenerative dementias. Characteristic patterns of regional glucose metabolism have been used to classify the dementia subtypes, namely Alzheimer's dementia (AD), frontotemporal dementia (FTD), diffuse Lewy body (DLBD) and vascular dementia (VD). We undertook this study to assess the utility of FDG-PET in the differential diagnosis of dementia subtypes. One hundred and twenty-five patients diagnosed with dementia were referred from cognitive disorders and memory clinics of speciality neurology centres for the FDG-PET study. Imaging-based diagnosis of dementia type was established in 101 patients by visual assessment of individual scans by a PET physician blinded to the clinical diagnosis. The results were compared with an 18-month follow-up clinical assessment made by the specialist neurologist. Concordance of visual evaluation of FDG-PET scans with clinical diagnosis of the dementia type was achieved in 90% of patients scanned. This concordance was 93.4% for AD, 88.8% for FTD, 66.6% for DLBD and 92.3% for the other dementia syndromes. FDG-PET performed after the initial work-up of dementias is useful for supporting the clinical diagnosis of dementia subtype.

Keywords: AD; DLBD; FDG-PET; FTD; vascular dementia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A) Transaxial fused FDG-PET/CT images in a case of advanced AD showing symmetrical hypometabolism in both frontal and temporal cortices (arrow). B) Coronal fused FDG-PET/CT image showing hypometabolism in both parietal cortices (arrow). C) Sagittal fused FDG-PET/CT image showing hypometabolism in the precuneus (arrow). D) Lateral maximum intensity projection image showing hypometabolism in the parietal and frontal cortices with preserved metabolism in the sensorimotor, visual and occipital cortices, and both cerebellar hemispheres.
Figure 2
Figure 2
Transaxial fused FDG-PET/CT images in a case of fronto-temporal dementia showing hypometabolism in both frontal (A, arrow) and both anterior temporal cortices (B, arrow).
Figure 3
Figure 3
Transaxial fused FDG-PET/CT images in a case of DLBD showing hypometabolism in both frontal and parietal cortices (A) and also in the visual cortices (B, arrow). C) Lateral maximum intensity projection image showing hypometabolism in the visual cortices with preserved metabolism in the posterior cingulate (arrow).

Similar articles

Cited by

References

    1. Foster NL, Heidebrink JL, Clark CM, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Brain. 2007;130(Pt 10):2616–2635. doi: 10.1093/brain/awm177. - DOI - PubMed
    1. Minoshima S, Foster NL, Sima AA, et al. Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with Autopsy confirmation. Ann Neurol. 2001;50(3):358–365. doi: 10.1002/ana.1133. - DOI - PubMed
    1. Silverman DH, Small GW, Chang CY, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001;286(17):2120–2127. doi: 10.1001/jama.286.17.2120. - DOI - PubMed
    1. Albin RL, Minoshima S, D’Amato CJ, et al. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 1996;47(2):462–466. doi: 10.1212/WNL.47.2.462. - DOI - PubMed
    1. Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med. 1998;39(11):1875–1878. - PubMed

MeSH terms

Substances